Why is Shree Ganesh Bio falling/rising?

As of 31-Jul, Shree Ganesh Biotech India Ltd's stock price is currently at Rs. 0.80, reflecting an increase of Rs. 0.01 or 1.27%. Despite this slight uptick, the stock has recently hit a new 52-week low of Rs. 0.78 and has underperformed in the longer term, with a year-to-date decline of 23.08% and a one-year drop of 35.48%. The stock is trading below its moving averages across various time frames, indicating a bearish trend. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 15.71% compared to the five-day average. The company's fundamentals are weak, characterized by operating losses and a poor EBIT to interest ratio of 0.97, which suggests challenges in servicing its debt and low profitability, further contributing to the stock's negative sentiment. In the broader market context, Shree Ganesh Biotech's short-term performance has been slightly better than the benchmark Sensex, which also declined by 1.22% over the past week, while the stock fell by 1.23%. However, the company's long-term performance starkly contrasts with the Sensex's positive return of 3.90% year-to-date and 41.02% over three years. This divergence highlights the stock's struggles relative to the overall market, reinforcing the perception of it being a risky investment, especially given its negative EBITDA and declining profits over the past year.